Matinas Biopharma (MTNB) EPS (2013 - 2026)
Matinas Biopharma (MTNB) EPS from Dec 31, 2013 to Mar 31, 2026. The TTM Matinas Biopharma (MTNB) EPS is -$1.89. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Matinas Biopharma (MTNB) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -52.40% |
| 3 Years TTM | -26.37% |
| 5 Years TTM | -19.49% |
| 10 Years TTM | -13.10% |
| All Time TTM | -17.26% |
Annual EPS change of Matinas Biopharma (MTNB)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.30 | -81.43% |
| 2025 | -$1.61 | -66.14% |
| 2024 | -$4.77 | -9.70% |
| 2023 | -$5.28 | +9.24% |
| 2022 | -$4.83 | -10.21% |
| 2021 | -$5.38 | -4.05% |
| 2020 | -$5.61 | -0.42% |
| 2019 | -$5.63 | -9.35% |
| 2018 | -$6.21 | -25.08% |
| 2017 | -$8.29 | +26.95% |
| 2016 | -$6.53 | -18.25% |
| 2015 | -$7.99 | -49.49% |
| 2014 | -$15.82 | +172.98% |
| 2013 | -$5.80 | N/A |
Comparison Matinas Biopharma (MTNB) five years EPS CAGR with competitors
Matinas Biopharma (MTNB) five years EPS CAGR is -19.47%.